Dehui Zou

21PUBLICATIONS
73CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 05, 2026
Proteogenomic features define subtypes of mantle cell lymphoma.

Yuting Yan, Weihao Chen, Xinzhou Ge

|Feb 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Wenqiang Yan, Chenxing Du, Rui Lv

|Feb 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Yan Xie, Ke-Shu Zhou, Lan-Fang Li

|Sep 03, 2025
Monoclonal gammopathy defines distinct clinical subsets in chronic lymphocytic leukemia across therapeutic eras.

Yuting Yan, Bolin Yuan, Tonglu Qiu

|Sep 01, 2025
Two-year follow-up of relmacabtagene autoleucel in relapsed or refractory follicular lymphoma in RELIANCE study.

Yuqin Song, Dehui Zou, Haiyan Yang

|Aug 14, 2025
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Yan Xie, Ke-Shu Zhou, Lan-Fang Li

Pageof 4

Frequent Collaborators

10 joint publications

Shuhua Yi

9 joint publications

Gang An

6 joint publications

Wei Liu

6 joint publications

Yuting Yan